Figure 5.

Survival according to 6-IA risk in patients bearing tumor with methylated MGMT promoter. Kaplan-Meier curves show OS of patients bearing tumors with methylated MGMT promoters after subdivision into HR (black) and LR (grey) groups. The median OS was higher in LR than in HR patients from GSE13041 dataset (A), TCGA dataset (B), Agilent local cohort (C) and RT-Q-PCR local cohort (D).

VaulĂ©on et al. BMC Medical Genomics 2012 5:41   doi:10.1186/1755-8794-5-41
Download authors' original image